🇺🇸 FDA
Patent

US 6063371

Pharmaceutical compositions comprising a soluble interleukin-4 receptor

expired A61KA61K38/00A61K38/193

Quick answer

US patent 6063371 (Pharmaceutical compositions comprising a soluble interleukin-4 receptor) held by The United States of America as represented by the Secretary of the Army expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61K38/193